Trials / Completed
CompletedNCT03691337
Fascia Iliaca Blocks for Total Hip Arthroplasty
Fascia Iliaca Block for Analgesia in Unilateral Direct Anterior Approach Total Hip Arthroplasty
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- New York School of Regional Anesthesia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The development of minimal-incision techniques for total hip arthroplasty (THA) with preservation of soft tissue is generally associated with reduction of postoperative pain and increased patient comfort. Although this technique requires a smaller incision than other approaches used for hip surgery, adequate postoperative pain management remains crucial for enhanced recovery and early rehabilitation. The fascia iliaca block (FIB) is commonly used to enhance analgesia after hip replacement surgery, however the effect of FIB volume on analgesia quality and sensory-motor blockade have not been adequately studied. In this study, total postsurgical opioid consumption (morphine equivalents IV in hospital and oral at home) through the first postoperative week will be compared and extent and duration of sensory motor block through the 2-day inpatient stay will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Marcaine 0.25 % Injectable Solution | Fascia iliaca block with volume 0.11 mL x subject height |
| DRUG | Marcaine 0.25 % Injectable Solution | Fascia iliaca block with volume 0.22 mL x subject height |
| DRUG | Sodium chloride | Fascia iliaca block with volume 0.11 mL x subject height |
Timeline
- Start date
- 2018-05-15
- Primary completion
- 2019-11-12
- Completion
- 2019-12-04
- First posted
- 2018-10-01
- Last updated
- 2020-09-10
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03691337. Inclusion in this directory is not an endorsement.